Skip to main content
SpringerLink
Log in

Endocrine System

  • Chapter
  • First Online:
Synopsis of Pathophysiology in Nuclear Medicine

Abstract

The thyroid gland develops from the foramen cecum of the tongue, to which it is connected by the thyroglossal duct. It descends during fetal life to reach the anterior neck by about the seventh week. Absent or aberrant descent results in ectopic locations, including the sublingual region and superior mediastinum.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pankow BG, Michalak J, McGee MK (1985) Adult human thyroid weight. Health Phys 49:1097–1103

    CAS  PubMed  Google Scholar 

  2. Mochizuki Y, Mowafy R, Pasternack B (1963) Weights of human thyroids in New York City. Health Phys 9:1299–1301

    CAS  PubMed  Google Scholar 

  3. Wolff J (1964) Transport of iodide and other anions in the thyroid gland. Physiol Rev 44:45

    CAS  PubMed  Google Scholar 

  4. De la Vieja A, Dohan O, Levy O, Carrasco N (2000) Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiol Rev 80:1083–1105

    Google Scholar 

  5. Sarkar SD, Savitch I (2004) Management of thyroid cancer. Appl Radiol 33:34–45

    Google Scholar 

  6. Sarkar SD (1996) Thyroid pathophysiology. In: Sandler MP, Coleman RE, Th. Wackers FJ (eds) Diagnostic nuclear medicine. Williams and Wilkins, Baltimore, pp 899–909

    Google Scholar 

  7. Cooper DS (2005) Antithyroid drugs. N Engl J Med 352:905–917

    CAS  PubMed  Google Scholar 

  8. Malozowski S, Chiesa A (2010) Propylthiouracil-induced hepatotoxicity and death. Hopefully, never more. J Clin Endocrinol Metab 95:3161–3163

    CAS  PubMed Central  PubMed  Google Scholar 

  9. Silberstein EB, Alavi A, Balon HR et al (2012) The SNM practice guideline for therapy of thyroid disease with 131I. J Nucl Med 53

    Google Scholar 

  10. Tala H, Robbins R, Fagin JA et al (2011) Five-year survival is similar in thyroid cancer patients with distant metastases prepared for radioactive iodine therapy with either thyroid hormone withdrawal or recombinant human TSH. J Clin Endocrinol Metab 96:2105–2111

    CAS  PubMed  Google Scholar 

  11. Sarkar SD, Afriyie MO, Palestro CJ (2001) Recombinant human thyroid-stimulating-hormone-aided scintigraphy: comparison of imaging at multiple times after I-131 administration. Clin Nucl Med 26:392–395

    CAS  PubMed  Google Scholar 

  12. Hooft L, Hoekstra OS, Deville W et al (2001) Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer. J Clin Endocrinol Metab 86:3779–3786

    CAS  PubMed  Google Scholar 

  13. Chin BB, Patel P, Cohade C et al (2004) Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography in well-differentiated thyroid carcinoma. J Clin Endocrinol Metab 89:91–95

    CAS  PubMed  Google Scholar 

  14. Moog F, Linke R, Manthey N et al (2000) Influence of thyroid stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma. J Nucl Med 41:1989–1995

    CAS  PubMed  Google Scholar 

  15. Akamizu T, Satoh T, Isozaki O et al (2012) Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys. Thyroid 22:661–679

    CAS  PubMed Central  PubMed  Google Scholar 

  16. Fradkin JE, Wolff J (1983) Iodide-induced thyrotoxicosis. Medicine 62:1–20

    CAS  PubMed  Google Scholar 

  17. Laurberg P, Pedersen KM, Hreidarsson A et al (1998) Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab 83:765

    CAS  PubMed  Google Scholar 

  18. Bogazzi F, Bartalena L, Gasperi M et al (2001) The various effects of amiodarone on thyroid function. Thyroid 11:511–519

    CAS  PubMed  Google Scholar 

  19. Daniels GH (2001) Amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 86:3–8

    CAS  PubMed  Google Scholar 

  20. Laurie AJ, Lyon SG, Lasser EC (1992) Contrast material iodides: potential effects on radioactive iodine thyroid uptake. J Nucl Med 33:237–238

    CAS  PubMed  Google Scholar 

  21. Sarkar SD, Becker DV (1995) Thyroid uptake and imaging. In: Becker KL (ed) Principles and practice of endocrinology and metabolism. Lippincott, Philadelphia, pp 307–313

    Google Scholar 

  22. Sarkar SD, Kalapparambath T, Palestro CJ (2002) Comparison of I-123 and I-131 for whole body imaging in thyroid cancer. J Nucl Med 43:632–634

    PubMed  Google Scholar 

  23. Ward LS, Santarosa PL, Granja F et al (2003) Low expression of sodium iodide symporter identifies aggressive thyroid tumors. Cancer Lett 200:85–91

    CAS  PubMed  Google Scholar 

  24. Bertagna F, Treglia G, Piccardo G et al (2012) Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. J Clin Endocrinol Metab 97:3866–3875

    CAS  PubMed  Google Scholar 

  25. Mitchell JC, Grant F, Evenson AR, Parker JA, Hasselgren PO, Parangi S (2005) Preoperative evaluation of thyroid nodules with 18FDG-PET/CT. Surgery 138:1166–1174

    PubMed  Google Scholar 

  26. Ridgway EC (1992) Clinician’s evaluation of a solitary thyroid nodule. J Clin Endocrinol Metab 74:231–235

    CAS  PubMed  Google Scholar 

  27. Ross DS (1991) Evaluation of the thyroid nodule. J Nucl Med 32:2181–2192

    CAS  PubMed  Google Scholar 

  28. Holm LE, Blomgren H, Lowhagen T (1985) Cancer risks in patients with chronic autoimmune thyroiditis. N Engl J Med 312:601–604

    CAS  PubMed  Google Scholar 

  29. Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo L et al (1992) Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 93:363–369

    CAS  PubMed  Google Scholar 

  30. Pacini F, Burroni L, Ciuoli C, Di Cairano G, Guarino E (2004) Management of thyroid nodules: a clinicopathological, evidence-based approach. Eur J Nucl Med Mol Imaging 31:1443–1449

    PubMed  Google Scholar 

  31. Liu Y (2009) Clinical significance of thyroid uptake on F18-fluorodeoxyglucose positron emission tomography. Ann Nucl Med 23:17–23

    PubMed  Google Scholar 

  32. Soto GD, Halperin I, Squarcia M, Lomeña F, Domingo MP (2010) Update in thyroid imaging. The expanding world of thyroid imaging and its translation to clinical practice. Hormones 9:287–298

    PubMed  Google Scholar 

  33. Fletcher JW, Djulbegovic B, Soares HP et al (2008) Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 49:480–508

    PubMed  Google Scholar 

  34. Atkins MB, Mier JW, Parkinson DR et al (1988) Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. N Engl J Med 318:1557–1563

    CAS  PubMed  Google Scholar 

  35. Fernandez-Soto L, Gonzalez A, Escobar-Jimenez F et al (1998) Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. Arch Intern Med 158:1445–1448

    CAS  PubMed  Google Scholar 

  36. Dang AH, Hershman JM (2002) Lithium-associated thyroiditis. Endocr Pract 8:232–236

    PubMed  Google Scholar 

  37. Amino N, Tada H, Hidaka Y et al (1999) Screening for postpartum thyroiditis. J Clin Endocrinol Metab 84:1813

    CAS  PubMed  Google Scholar 

  38. Stagnaro-Green A (2002) Postpartum thyroiditis. J Clin Endocrinol Metab 87:4042–4047

    CAS  PubMed  Google Scholar 

  39. Premawardhana LDKE, Parkes AB, John R et al (2004) Thyroid peroxidase antibodies in early pregnancy: utility for prediction of postpartum thyroid dysfunction and implications for screening. Thyroid 14:610–615

    CAS  PubMed  Google Scholar 

  40. De Bruin TWA, Riekhoff FPM, de Boer JJ (1990) An outbreak of thyrotoxicosis due to atypical subacute thyroiditis. J Clin Endocrinol Metab 70:396–402

    PubMed  Google Scholar 

  41. Brusco F, Gonzalez G, Soto N et al (2004) Successful treatment of hyperthyroidism with amiodarone in a patient with propylthiouracil-induced acute hepatic failure. Thyroid 14:862–865

    PubMed  Google Scholar 

  42. Vestergaard P, Rejnmark L, Weeke J et al (2002) Smoking as a risk factor for Graves’ disease, toxic nodular goiter, and autoimmune hypothyroidism. Thyroid 12:69–75

    PubMed  Google Scholar 

  43. Fountoulakis S, Tsatsoulis A (2004) On the pathogenesis of autoimmune thyroid disease: a unifying hypothesis. Clin Endocrinol 60:397–409

    Google Scholar 

  44. Li Y, Teng D, Shan Z et al (2008) Antithyroperoxidase and antithyroglobulin antibodies in a five-year followup survey of populations with different iodine intakes. J Clin Endocrinol Metab 93:1751–1757

    CAS  PubMed  Google Scholar 

  45. Nygaard B, Knudsen JH, Hegedus L et al (1997) Thyrotropin receptor antibodies and Graves’ disease, a side-effect of I-131 treatment in patients with nontoxic goiter. J Clin Endocrinol Metab 82:2926–2930

    CAS  PubMed  Google Scholar 

  46. Surks MI, Ortiz E, Daniels GH et al (2004) Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291:228–238

    CAS  PubMed  Google Scholar 

  47. Weetman AP (2000) Graves disease. N Engl J Med 343:1236–1248

    CAS  PubMed  Google Scholar 

  48. Klein I, Ojamaa K (2001) Thyroid hormone and the cardiovascular system. N Engl J Med 344:501–509

    CAS  PubMed  Google Scholar 

  49. Kahaly GJ, Dillmann WH (2005) Thyroid hormone action in the heart. Endocr Rev 26:704–728

    CAS  PubMed  Google Scholar 

  50. Sarkar SD (2006) Benign thyroid disease: what is the role of nuclear medicine? Semin Nucl Med 36:185–193

    PubMed  Google Scholar 

  51. Ahmed A, Craig W, Krukowski ZH (2012) Quality of life after surgery for Graves’ disease: comparison of those having surgery intended to preserve thyroid function with those having ablative surgery. Thyroid 22:494–500

    Google Scholar 

  52. Burch HB, Burman KD, Cooper DS (2012) A 2011 survey of clinical practice patterns in the management of Graves’ disease. J Clin Endocrinol Metab 97:4549–4558

    CAS  PubMed  Google Scholar 

  53. Wang CA (1976) The anatomic basis of parathyroid surgery. Ann Surg 183:271–275

    CAS  PubMed Central  PubMed  Google Scholar 

  54. Akerstrom G, Malmaeus J, Bergstrom R (1984) Surgical anatomy of human parathyroid glands. Surgery 95:15–21

    Google Scholar 

  55. Delaney SE, Wermers RA, Thompson GB, Hodgson SF, Dinneen SF (1999) Mediastinal parathyroid carcinoma. Endocr Pract 5:133–136

    CAS  PubMed  Google Scholar 

  56. Quiros RM, Warren W, Prinz RA (2004) Excision of a mediastinal parathyroid gland with use of video-assisted thoracoscopy, intraoperative 99mTc-sestamibi scanning, and intraoperative monitoring of intact parathyroid hormone. Endocr Pract 10:45–48

    PubMed  Google Scholar 

  57. Maxon HR, Elgazzar AH (1988) Parathyroid imaging. In: Gelfand G, Thomas S (eds) Effective use of computers in nuclear medicine. McGraw Hill, New York, pp 485–496

    Google Scholar 

  58. Akerstrom G, Grimelius L, Johansson H, Lundquist H, Pertoft H, Bergstrom R (1981) The parenchymal cell mass in normal human parathyroid glands. Acta Pathol Microbiol Immunol Scand 89(A):367

    Google Scholar 

  59. Akerstrom G, Rudberg C, Grimelius L et al (1986) Histologic parathyroid abnormalities in an autopsy series. Hum Pathol 17:520–527

    CAS  PubMed  Google Scholar 

  60. Heath H III (1991) Clinical spectrum of primary hyperparathyroidism: evolution with changes in medical practice and technology. J Bone Mineral Res 6:S63–S70

    Google Scholar 

  61. Herfarth KK, Wells SA (1997) Parathyroid glands and the multiple endocrine neoplasia syndromes and familial hypocalciuric hypercalcemia. Semin Surg Oncol 13:114–124

    CAS  PubMed  Google Scholar 

  62. Duh QY, Hybarger CP, Geist R, Gamsu G, Goodman PC, Gooding GA, Clark OH (1987) Carcinoids associated with multiple endocrine neoplasia syndromes. Am J Surg 154:142–148

    CAS  PubMed  Google Scholar 

  63. Beus KS, Stack BC (2004) Synchronous thyroid pathology in patients presenting with primary hyperparathyroidism. Am J Otolaryngol 25:308–312

    PubMed  Google Scholar 

  64. Sidhu S, Campbell P (2000) Thyroid pathology associated with primary hyperparathyroidism. Aust N Z J Surg 70:285–287

    CAS  PubMed  Google Scholar 

  65. Hedman IL, Tisell LE (1984) Associated hyperparathyroidism and non-medullary thyroid carcinoma: the etiological role of radiation. Surgery 95:392–397

    CAS  PubMed  Google Scholar 

  66. Thompson NW, Eckhauser FE, Harness JK (1982) The anatomy of primary hyperparathyroidism. Surgery 92:814–821

    CAS  PubMed  Google Scholar 

  67. Simeone DM, Sandelin K, Thompson NW (1995) Undescended superior parathyroid gland: a potential cause of failed cervical exploration for hyperparathyroidism. Surgery 118:949–956

    CAS  PubMed  Google Scholar 

  68. Tezelman S, Shen W, Shaver JK et al (1993) Double parathyroid adenomas: clinical and biochemical characteristics before and after parathyroidectomy. Ann Surg 218:300–309

    CAS  PubMed Central  PubMed  Google Scholar 

  69. Bartsch D, Nies C, Hasse C et al (1995) Clinical and surgical aspects of double adenoma in patients with primary hyperparathyroidism. Br J Surg 82:926–929

    CAS  PubMed  Google Scholar 

  70. Nguyen BD (1999) Parathyroid imaging with Tc-99m sestamibi planar and SPECT scintigraphy. Radiographics 19:601–614

    CAS  PubMed  Google Scholar 

  71. Clark OH, Duh QY (1989) Primary hyperparathyroidism: a surgical perspective. Endocrinol Metab Clin North Am 18:701–714

    CAS  PubMed  Google Scholar 

  72. McHenry CR, Lee K, Saadey J et al (1996) Parathyroid localization with technetium-99 m-sestamibi: a prospective evaluation. J Am Coll Surg 183:25–30

    CAS  PubMed  Google Scholar 

  73. Bergenfelz A, Tennvall J, Valdermarsson S et al (1997) Sestamibi versus thallium subtraction scintigraphy in parathyroid localization: a prospective comparative study in patients with predominantly mild primary hyperparathyroidism. Surgery 121:601–605

    CAS  PubMed  Google Scholar 

  74. Rogers LA, Fetter BF, Peete WPJ (1969) Parathyroid cyst and cystic degeneration of parathyroid adenoma. Arch Pathol 88:476–479

    CAS  PubMed  Google Scholar 

  75. Fallon MD, Haines JW, Teitelbaum SL (1982) Cystic parathyroid gland hyperplasia-hyperparathyroidism presenting as a neck mass. Am J Clin Pathol 77:104–107

    CAS  PubMed  Google Scholar 

  76. Turner WJD, Baergen RN, Pellitteri PK, Orloff LA (1996) Parathyroid lipoadenoma: case report and review of the literature. Otolaryngol Head Neck Surg 114:313–316

    CAS  PubMed  Google Scholar 

  77. Cummings CW (2005) Otolaryngology: head and neck surgery, 4th edn. Mosby, Philadelphia

    Google Scholar 

  78. Cheng L, Bostwick DG (2011) Endocrine pathology. In: Essentials of anatomic pathology, 3rd edn. Springer, Berlin, pp 927–928

    Google Scholar 

  79. Rinsho N (1995) Primary hyperparathyroidism, pathologic findings and ultrastructure. Jpn J Clin Med 53:861–863

    Google Scholar 

  80. Chen CC, Premkumar A, Hill SC, Skarulis MC, Spiegel AM (1995) Tc-99 m sestamibi imaging of a hyperfunctioning parathyroid autograft with Doppler ultrasound and MRI correlation. Clin Nucl Med 20:222–225

    CAS  PubMed  Google Scholar 

  81. Lee VS, Spritzer CE, Coleman RE, Wilkinson RH Jr, Coogan AC, Leight GS Jr (1995) Hyperparathyroidism in high-risk surgical patients: evaluation with double-phase technetium-99 m sestamibi imaging. Radiology 197:627–633

    CAS  PubMed  Google Scholar 

  82. Walker RP, Paloyan E, Gopalsami C (2004) Symptoms in patients with primary hyperparathyroidism: muscle weakness or sleepiness. Endocr Pract 10:404–408

    PubMed  Google Scholar 

  83. Wang CA (1977) Parathyroid re-exploration: a clinical and pathological study of 112 cases. Ann Surg 186:140

    CAS  PubMed Central  PubMed  Google Scholar 

  84. Assalia A, Inabnet WB (2004) Endoscopic parathyroidectomy. Otolaryngol Clin North Am 37:871–886

    PubMed  Google Scholar 

  85. O’Doherty MJ, Kettle AG (2003) Parathyroid imaging: preoperative localisation. Nucl Med Commun 24:125–131

    PubMed  Google Scholar 

  86. Mitchell BK, Merrell RC, Kinder BK (1995) Localization studies in patients with hyperparathyroidism. Endocr Surg 75:483–498

    CAS  Google Scholar 

  87. Kao A, Shiau YC, Tsai SC, Wang JJ, Ho ST (2002) Technetium-99 m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression. Eur J Nucl Med Mol Imaging 29:1012–1015

    CAS  PubMed  Google Scholar 

  88. Goris ML, Basso LV, Keeling C (1991) Parathyroid imaging. J Nucl Med 32:887–889

    CAS  PubMed  Google Scholar 

  89. O’Doherty MJ, Kettle AG, Wells P, Collins RE, Coakley AJ (1992) Parathyroid imaging with technetium 99 m-sestamibi: preoperative localization and tissue uptake studies. J Nucl Med 33:313–318

    PubMed  Google Scholar 

  90. Takebayashi S, Hidai H, Chiba T, Takaga Y, Nagatani Y, Matsubara S (1999) Hyperfunctional parathyroid glands with Tc-99 m MIBI scan: semiquantitative analysis correlated with histologic findings. J Nucl Med 40:1792–1797

    CAS  PubMed  Google Scholar 

  91. Sandrock D, Merino MJ, Norton JA, Neumann RD (1993) Ultrastructural histology correlates with results of thallium-201/technetium-99 m parathyroid subtraction scintigraphy. J Nucl Med 34:24–29

    CAS  PubMed  Google Scholar 

  92. Naddaf S, Anim JJ, Farghaly MM, Behbehani AE, Alshomar KA, Elgazzar AH (2004) Ultrastructure of hyperfunctioning parathyroid glands: does it explain various patterns of sestamibi uptake. Proceedings of the 9th annual Health science poster day and conference, Kuwait, April 19–21, pp 61

    Google Scholar 

  93. Dontu VS, Kettle AG, O’Doherty MJ, Coakley AJ (2004) Optimization of parathyroid imaging by simultaneous dual energy planar and single photon emission tomography. Nucl Med Commun 25:1089–1093

    PubMed  Google Scholar 

  94. Al-Sobaei S (2005) Proceedings of the first gulf nuclear medicine congress. Riyadh, 1–3 Mar KFSH

    Google Scholar 

  95. Melton GB, Somervell H, Friedman KP, Zeiger MA, Cahid CA (2005) Interpretation of 99mTc sestamibi parathyroid SPECT scan is improved when read by the surgeon and nuclear medicine physician together. Nucl Med Communication 26:633–638

    Google Scholar 

  96. Slater A, Gleeson FV (2005) Increased sensitivity and confidence of SPECT over planar imaging in dual-phase sestamibi for parathyroid adenoma detection. Clin Nucl Med 30:1–3

    PubMed  Google Scholar 

  97. Vaz A, Griffiths M (2011) Parathyroid imaging and localization using SPECT/CT: initial results. J Nucl Med Technol 39:195–200

    PubMed  Google Scholar 

  98. Takahashi H et al (2013) Fusion images of MIBI SPECT and MDCT improve diagnostic performance of localization study in hyperparathyroidism with multigland disease. J Nucl Med 54:44p

    Google Scholar 

  99. Beggs AD, Hain SF (2005) Localization of parathyroid adenomas using 11C-methionine positron emission tomography. Nuclear Medicine communication 26:133–136

    Google Scholar 

  100. Lezaic L, Kocjan T, Jesterle M et al (2013) Usefulness of F18-fluorocholine PET/CT for preoperative localization of parathyroid adenoma. J Nucl Med 54:43p

    Google Scholar 

  101. Aron DC, Tyrrell JB (1997) Glucocorticoids and adrenal androgens. In: Greenspan FS, Strewler GJ (eds) Basic and clinical endocrinology, 5th edn. Appleton and Lange, Norwalk, p 318

    Google Scholar 

  102. Goldfien A (1997) Adrenal medulla. In: Greenspan FS, Strewler GJ (eds) Basic and clinical endocrinology, 5th edn. Appleton and Lange, Norwalk, p 382

    Google Scholar 

  103. Ryan JJ, Rezkalla MA, Rizk SN, Peterson KG, Wiebe RH (1995) Testosterone-secreting adrenal adenoma that contained crystalloids of Reinke in an adult female patient. Mayo Clin Proc 70:380–383

    CAS  PubMed  Google Scholar 

  104. Lynn MD, Gross MD, Shapiro B, Bassett D (1986) The influence of hypercholesterolemia on the adrenal uptake and metabolic handling of I-131 6β-iodomethyl-19-norcholesterol (NP-59). Nucl Med Comm 1:631–635

    Google Scholar 

  105. Hedeland H, Ostberg G, Hokfelt B (1968) On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand 184:211–214

    CAS  PubMed  Google Scholar 

  106. Copeland PM (1983) The incidentally discovered adrenal mass. Ann Intern Med 98:940–945

    CAS  PubMed  Google Scholar 

  107. Volpe C, Enberg U, Sjögren A et al (2008) The role of adrenal scintigraphy in the preoperative management of primary aldosteronism. Scand J Surg 97:248–253

    CAS  PubMed  Google Scholar 

  108. Evangelista L, De Falco T, di Nuzzo C et al (2008) Utility of adrenal cortical scintigraphy with I-6-$-methyl-131 norcholesterol in a case of mismatch between morphological and functional PET imaging. Thyroid Science 3:CR1–CR3

    Google Scholar 

  109. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004) Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27:193–202

    PubMed  Google Scholar 

  110. Huether SE, Tomky D (1998) Alterations of hormonal regulation. In: McCance KL, Huether SE (eds) Pathophysiology, the biologic basis for disease in adults and children, 3rd edn. Mosby, St Louis, p 700

    Google Scholar 

  111. Spencer RP (1998) Tumor-seeking radiopharmaceuticals: nature and mechanisms. In: Murray IP, Ell PJ (eds) Nuclear medicine in clinical diagnosis and treatment, 2nd edn. Churchill Livingstone, Hong Kong, p 764

    Google Scholar 

  112. Elgazzar AH, Gelfand MJ, Washburn LC, Clark J, Nagaraj N, Cummings D, Hughes J et al (1995) I-123 MIBG scintigraphy in adults, a report of clinical experience. Clin Nucl Med 20:147

    CAS  PubMed  Google Scholar 

  113. Gelfand MJ, Elgazzar AH, Kriss VM, Masters PR, Golsch GJ (1994) Iodine-123 MIBG SPECT versus planar imaging in children with neural crest tumors. J Nucl Med 35:1753–1756

    CAS  PubMed  Google Scholar 

  114. Parisi MT, Sandler ED, Hattner RS (1992) The biodistribution of metaiodobenzylguanidine. Semin Nucl Med 22:46–48

    CAS  PubMed  Google Scholar 

  115. Okuyama C, Ushijima Y, Kubota T, Yoshida T, Nakai T, Kobayashi K, Nishimura T (2003) 123I-Metaiodobenzylguanidine uptake in the nape of the neck of children: likely visualization of brown adipose tissue. J Nucl Med 44:1421–1425

    CAS  PubMed  Google Scholar 

  116. Shapiro B, Copp JE, Sisson JC, Eyre PL, Wallis J, Beierwaltes WH (1985) Iodine-131 metaiodobenzyl-guanidine in the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med 26:576

    CAS  PubMed  Google Scholar 

  117. Paltiel HJ, Gelfand MJ, Elgazzar AH, Washburn LC, Harris RE, Masters PR, Golsch GJ (1994) Neural crest tumors: I-123 MIBG imaging in children. Radiology 190:118

    Google Scholar 

  118. Shalaby-Rana E, Majd M, Andrich MP, Movassaghi N (1997) In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome. Clin Nucl Med 22:315–319

    CAS  PubMed  Google Scholar 

  119. Kropp J, Hofmann M, Bihl H (1997) Comparison of MIBG and pentetreotide scintigraphy in children with neuroblastoma. Is the expression of somatostatin receptors a prognostic factor? Anticancer Res 17:1583–1588

    CAS  PubMed  Google Scholar 

  120. Tenenbaum F, Lumbroso J, Schlumberger M, Mure A, Plouin PF, Caillou B, Parmentier C (1995) Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. J Nucl Med 36:1–6

    CAS  PubMed  Google Scholar 

  121. Pashankar FD, O’Dorisio MS, Menda Y (2005) MIBG and somatostatin receptor analogs in children: current concepts on diagnostic and therapeutic use. J Nucl Med 46(Suppl 1):55S–61S

    CAS  PubMed  Google Scholar 

  122. Manil L, Edeline V, Jlumbroso J, Lequen H, Zucker JM (1996) Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors. J Nucl Med 37:893–896

    CAS  PubMed  Google Scholar 

  123. Krausz Y, Keidar Z, Kogan I, Even-Sapir E, Bar-Shalom R, Engel A, Rubinstein R et al (2003) SPECT/CT hybrid imaging with 111In-pentetreotide in assessment of neuroendocrine tumours. Clin Endocrinol (Oxf) 59:565–573

    Google Scholar 

  124. Andersson P, Forssel-Aronsson E, Johanson V, Wangberg B, Nilsson O, Fjalling M, Ahlman H (1996) Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe 1-Octreotide. J Nucl Med 37:2002–2006

    CAS  PubMed  Google Scholar 

  125. Trampal C, Engler H, Juhlin C, Bergstrom M, Langstrom B (2004) Pheochromocytomas: detection with C-11 hydroxyephedrine PET. Radiology 230:423–428

    PubMed  Google Scholar 

  126. Pacak K, Eisenhofer G, Carrasquillo JA, Chen CC, Li ST, Goldstein DS (2001) 6-[18F]Fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension 7:6–8

    Google Scholar 

  127. Ilias I, Yu J, Carrasquillo JA, Chen CC, Eisenhofer G, Whatley M, McElroy B et al (2003) Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J Clin Endocrinol Metab 88:4083–4087

    CAS  PubMed  Google Scholar 

  128. Brunt LM, Moley JF (2001) Adrenal incidentaloma. World J Surg 25:905–913

    CAS  PubMed  Google Scholar 

  129. Mantero F, Masini AM, Opocher G, Giovagnetti M, Arnaldi G (1997) Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group. Horm Res 47:284–289

    CAS  PubMed  Google Scholar 

  130. Minn H, Salonen A, Friberg J, Roivainen A, Viljanen T, Langsjo J, Salmi J et al (2004) Imaging of adrenal incidentalomas with PET using C-11 metomidate and 18F-FDG. J Nucl Med 45:972–979

    CAS  PubMed  Google Scholar 

  131. Khan TS, Sundin A, Juhlin C, Langstrom B, Bergström M, Eriksson B (2003) 11C-metomidate PET imaging of adrenocortical cancer. Eur J Nucl Med Mol Imaging 30:403–410

    PubMed  Google Scholar 

  132. Rubello D, Bui C, Casara D et al (2002) Functional scintigraphy of the adrenal gland. Eur J Endocrinol 147:13–28

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Kuwait University, Safat, Kuwait

    Abdelhamid H. Elgazzar

Authors
  1. Abdelhamid H. Elgazzar
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Elgazzar, A.H. (2014). Endocrine System. In: Synopsis of Pathophysiology in Nuclear Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-03458-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-03458-4_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-03457-7

  • Online ISBN: 978-3-319-03458-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation